< Back to previous page
Project
Engineering, evaluation and validation of safer vectors for gene therapy
The strategic objective of the proposed project is the development of gamma retroviral vectors (prototype: moloney murine leukemia virus (MLV)) with a reduced chance of insertional mutagenesis.
Date:1 Jan 2015 → 30 Sep 2019
Keywords:safer vectors, gene therapy, Engineering, evaluation, validation
Disciplines:Microbiology, Systems biology, Laboratory medicine, Biomaterials engineering, Biological system engineering, Biomechanical engineering, Other (bio)medical engineering, Environmental engineering and biotechnology, Industrial biotechnology, Other biotechnology, bio-engineering and biosystem engineering
Project type:PhD project